Author:
Calabria Ferdinando,Leporace Mario,Colandrea Marzia,Cascini Giuseppe L.,Schillaci Orazio
Publisher
Springer Nature Switzerland
Reference93 articles.
1. No Authors. FDA approves 11C-choline for PET in prostate cancer. J Nucl Med. 2012;53(12):11N.
2. Lodi F, Malizia C, Castellucci P, et al. Synthesis of oncological [11C]radiopharmaceuticals for clinical PET. Nucl Med Biol. 2012;39:447–60.
3. Hara T, Kosaka N, Kishi H. Development of (18)F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging. J Nucl Med. 2002;13:187–99.
4. Schmaljohann J, Schirrmacher E, Wängler B, et al. Fully automated SPE-based synthesis and purification of 2-[18F]fluoroethyl-choline for human use. Nucl Med Biol. 2011;38:165–70.
5. DeGrado TR, Baldwin SW, Wang S, et al. Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers. J Nucl Med. 2001;42:1805–14.